Nuclear localization of human AP endonuclease 1 (HAP1/Ref-1) associates with prognosis in early operable non-small cell lung cancer (NSCLC)

Journal of Pathology

Volumn 189, Issue 3, 1999, Pages 351-357

  Kakolyris, Stylianos ^a,b   Giatromanolaki, Alexandra ^a,b   Koukourakis, Michael ^b   Kaklamanis, Loukas ^a   Kanavaros, Panagiotis ^b   Hickson, Ian D ^a   Barzilay, Gil ^a   Georgoulias, Vassilis ^b   Gatter, Kevin C ^a   Harris, Adrian L ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

HAP1; Immunohistochemistry; NSCLC; p53

Indexed keywords

DEOXYRIBONUCLEASE I;

ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA REPAIR; ENZYME LOCALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOGENESIS; LUNG CARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING;

AGED; CARBON-OXYGEN LYASES; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; DEOXYRIBONUCLEASE IV (PHAGE T4-INDUCED); DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; SURVIVAL RATE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032851264     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199911)189:3<351::AID-PATH435>3.0.CO;2-1     Document Type: Article

References (36)

1. Demple B, Harrison L. Repair of oxidative damage to DNA: enzymology and biology. Annu Rev Biochem 1994; 63: 915-948.
2. Larson K, Sahm J, Shenkar R, Strauss B. Methylation-induced blocks to in vitro DNA replication. Mutat Res 1985; 150: 77-84.
3. Loeb LA, Preston BD. Mutagenesis by apurinic/apyrimidinic sites. Annu Rev Genet 1986; 20: 201-230.
4. Craig N, Johnson S, Komachi K, Lindahl T. DNA repair. In: Alberts B, Bray D, Lewis J, Raff M, Roberts K, Watson D, eds. Molecular Biology of the Cell, 3rd edn. New York: Garland, 1994: 242-251.
5. Robson CN, Hickson ID. Isolation of cDNA clones encoding a human apurinic/apyrimidinic endonuclease that corrects DNA repair and mutagenesis defects in E. coli xth (exonuclease) mutants. Nucleic Acids Res 1991; 19: 5519-5523.
6. Seki S, Akiyama K, Watanabe S, Hatsushika M, Ikeda S, Tsutsui K. cDNA and deduced amino acid sequence of a mouse DNA repair enzyme (APEX nuclease) with significant homology to Escherichia coli exonuclease III. J Biol Chem 1991; 266: 20797-20802.
7. Demple B, Herman R, Chen DS. Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: definition of a family of DNA repair enzymes. Proc Natl Acad Sci U S A 1991; 88: 11450-11454.
8. Xanthoudakis S, Curran T. Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J 1992; 11: 653-665.
9. Xanthoudakis S, Miao GG, Wang F, Pan YC, Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J 1992; 11: 3323-3335.
10. Frame MC, Wilkie NM, Darling AJ, et al. Regulation of AP-1/DNA complex formation in vivo. Oncogene 1991; 6: 205-209.
11. Curran T, Franza BJ. Fos and Jun: the AP-1 connection. Cell 1988; 55: 395-397.
12. Abate C, Luk D, Curran T. A ubiquitous nuclear protein stimulates the DNA-binding activity of fos and jun indirectly. Cell Growth Differ 1990; 1: 455-462.
13. Xanthoudakis S, Miao GG, Curran T. The redox and DNA-repair activities of Ref-1 are encoded by non-overlapping domains. Prof Natl Acad Sci U S A 1994; 91: 23-27.
14. Walker LJ, Robson CN, Black E, Gillespie D, Hickson ID. Identification of residues in the human DNA repair enzyme HAP 1 (Ref-1) that are essential for redox regulation of jun DNA binding. Mol Cell Biol 1993; 13: 5370-5376.
15. Jayaraman L, Murthy KG, Zhu C, Curran T, Xanthoudakis S, Prives C. Identification of redox/repair protein Ref-1 as a potent activator of p53. Genes Dev 1997; 11: 558-570.
16. Meira LB, Cheo DL, Hammer RE, Burns DK, Reis A, Friedberg EC. Genetic interaction between HAP1/Ref-1 and p53. Nature Genet 1997-17: 145.
17. Duguid JR, Eble JN, Wilson TM, Kelley MR. Differential cellular and subcellular expression of the human multifunctional apurinic/apyrimidinic endonuclease (APE/ref-1) DNA repair enzyme. Cancer Res 1995; 55: 6097-6102.
18. Kakolyris S, Kaklamanis L, Engels K, et al. Human AP endonuclease 1 (HAP1) expression in breast cancer correlates with lymph node status and angiogenesis. Br J Cancer 1998; 77: 1169-1173.
19. Kakolyris S, Kaklamanis L, Engels K, et al. Human AP endonuclease 1 (HAP1) expression in a colorectal adenoma-carcinoma sequence. Cancer Res 1997; 57: 1794-1796.
20. Kakolyris S, Kaklamanis L, Giatromanolaki A, et al. The expression and subcellular localization of human AP endonuclease 1 (HAP1/Ref-1) protein. A basis for its role in human disease. Histopathology 1998; 330: 561-569.
21. Ginsberg RJ, Kris MG, Armstrong JG. Non small cell lung cancer. In: De Vita VT, Hellman S, Rosenberg SA, eds. Cancer: Principles and Practice of Oncology 3rd edn. Philadelphia, PA: Lippincott, 1992: 673-722.
22. Svabo E, Riffe ME, Steinberg SM, Birrer MJ, Linnoila RI. Altered c-Jun expression: an early event in human lung carcinogenesis. Cancer Res 1996; 56: 305-315.
23. Giatromanolaki A, Koukourakis M, O'Byrne K, et al. Angiogenesis is a significant prognostic marker in operable non-small cell lung cancer. J Pathol 1996; 79: 80-88.
24. Fox SB, Turner GDH, Leek RD, Whitehouse RM, Gatter KC, Harris AL. The prognostic value of quantitative angiogenesis in breast cancer and role of adhesion molecule expression in tumour endothelium. Breast Cancer Res Treat 1995; 36: 219-226.
25. McLaren R, Kuzu I, Dunnill M, Harri AL, Lane D, Gatter KC. The relationship of p53 immunostaining to survival in carcinoma of the lung. Br J Cancer 1992; 66: 735-738.
26. Pezzella F, Turley H, Kuzu I, Gatter KC, Mason DY. Reversible p53 expression in lung cancer. Lancet 1992; 340: 922-925.
27. Pezzella F, Micklem K, Turley H, et al. Antibody for detecting p53 protein by immunohistochemistry in normal tissues. J Clin Pathol 1994; 47: 592-596.
28. Tungekar MF, Gatter KC, Dunnill MS, Mason DY. Ki-67 immunostaining and survival in operable lung cancer. Histopathology 1991; 19: 545-550.
29. Moulder JE, Rockwell S. Hypoxic fractions of solid tumours: experimental techniques, methods of analysis and a survey of existing data. Int J Radiat Oncol Biol Phys 1984; 10: 695-712.
30. Walker LJ, Craig RB, Harris AL, Hickson ID, A role for the human DNA repair enzyme HAP1 in cellular protection against DNA damaging agents and hypoxic stress. Nucleic Acids Res 1994; 22: 4884-4889.
31. Yao KS, Xanthoudakis S, Curran T, O'Dwyer PJ. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Mol Cell Biol 1994; 14: 5997-6003.
32. Driggers WJ, Grishko VI, Le Doux SP, Wilson GL. Defective repair of oxidative damage in the mitochondrial DNA of a xeroderma pigmentosum Group A cell line. Cancer Res 1996, 56: 1262-1266.
33. Tomkinson AE, Bonk RT, Linn S. Mitochondrial endonuclease activities specific for apurinic/apyrimidinic sites in DNA from mouse cells. J Biol Chem 1988; 263: 12 532-12 537.
34. Fontanini G, Vignati S, Bigini D, et al. Bc1-2 protein: a prognostic factor inversely correlated to p53 in non-small cell lung cancer. Br J Cancer 1995; 71: 1003-1007.
35. Shin DM, Kim J, Ro JY, et al. Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res 1994; 54: 321-326.
36. Walker C, Robertson LJ, Myskow NW, Pendleton N, Dixon G. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas. Br J Cancer 1994; 70: 297-303.